Clinical Trial Update: BRAVE Strategy - Breast Cancer Risk Assessment -achieVing Equity [NA]

View source ↗

Summary

The BRAVE Strategy trial evaluating breast cancer risk assessment and equity has completed enrollment and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Breast Cancer | NA | Status: COMPLETED | Results posted: 2025-08-28